14690 Federal Register / Vol. 76, No. 52 / Thursday, March 17, 2011 / Notices 

Drug Schedule 

Dihydrocodeine (9120) .................. II 

Oxycodone (9143) ......................... II 

Hydromorphone (9150) .................. II 

Diphenoxylate (9170) ..................... II 

Ecgonine (9180) ............................ II 

Hydrocodone (9193) ...................... II 

Levorphanol (9220) ........................ II 

Meperidine (9230) .......................... II 

Methadone (9250) ......................... II 

Methadone intermediate (9254) .... II 

Metopon (9260) ............................. II 

Dextropropoxyphene, bulk (9273) II 

Morphine (9300) ............................ II 

Oripavine (9330) ............................ II 

Thebaine (9333) ............................ II 

Opium extracts (9610) ................... II 

Opium fluid extract (9620) ............. II 

Opium tincture (9630) .................... II 

Opium, powdered (9639) ............... II 

Opium, granulated (9640) .............. II 

Levo-alphacetylmethadol (9648) ... II 

Oxymorphone (9652) ..................... II 

Noroxymorphone (9668) ................ II 

Alfentanil (9737) ............................. II 

Remifentanil (9739) ....................... II 

Sufentanil (9740) ........................... II 

Fentanyl (9801) .............................. II 

The firm plans to manufacture the 

listed controlled substances for internal 

use and for sale to other companies. 

Any other such applicant, and any 

person who is presently registered with 

DEA to manufacture such substances, 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than May 16, 2011. 

Dated: March 9, 2011. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2011–6157 Filed 3–16–11; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a), Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on September 10, 

2010, Cambrex Charles City, Inc., 1205 

11th Street, Charles City, Iowa 50616, 

made application by letter to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

4-Anilino-N-Phenethyl-4-Piperidine 

(ANPP) (8333), a basic class of 

controlled substance. 

The company plans to use this 

controlled substance in the manufacture 

of another controlled substance. 

Any other such applicant, and any 

person who is presently registered with 

DEA to manufacture such substances, 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than May 16, 2011. 

Dated: March 8, 2011. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2011–6156 Filed 3–16–11; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated November 18, 2010, 

and published in the Federal Register 

on December 3, 2010, (75 FR 75498), 

Agilent Technologies, 25200 

Commercentre Drive, Lake Forest, 

California 92630–8810, made 

application by letter to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the following basic classes of controlled 

substances: 

Drug Schedule 

Phencyclidine (7471) ..................... II 

1-piperidinocyclohexanecarbonitrile 

(8603).

II 

Benzoylecgonine (9180) ................ II 

The company plans to manufacture 

small quantities of the listed controlled 

substances for use in diagnostic 

products. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Agilent Technologies to manufacture 

the listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Agilent Technologies to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823(a), 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: March 9, 2011. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2011–6163 Filed 3–16–11; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated November 1, 2010, 

and published in the Federal Register 

on November 12, 2010, 75 FR 69464, 

Noramco Inc., 1440 Olympic Drive, 

Athens, Georgia 30601, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the following basic classes of controlled 

substances: 

Drug Schedule 

Codeine-N-Oxide (9053) .............. I 

Morphine-N-Oxide (9307) ............. I 

Amphetamine (1100) .................... II 

Methylphenidate (1724) ................ II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Hydrocodone (9193) ..................... II 

Morphine (9300) ........................... II 

Oripavine (9330) ........................... II 

Thebaine (9333) ........................... II 

Oxymorphone (9652) ................... II 

Noroxymorphone (9668) .............. II 

Alfentanil (9737) ........................... II 

Sufentanil (9740) .......................... II 

Carfentanil (9743) ......................... II 

Tapentadol (9780) ........................ II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution to its customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Noramco Inc., to manufacture the listed 

basic classes of controlled substances is 

consistent with the public interest at 

this time. DEA has investigated 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 76, No. 52 / Thursday, March 17, 2011 / Notices 14691 

Noramco Inc., to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823(a), 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: March 9, 2011. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2011–6155 Filed 3–16–11; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF LABOR 

Employment and Training 

Administration 

[TA–W–70,460] 

Delphi Steering, Including On-Site 

Leased Workers From Acro Service 

Corporation, Aerotek, Inc., Continental, 

Inc., Dynamic Corp., G-Tech 

Professional Staffing, Inc., Globaledge 

Technologies, Inc. (Formerly CAE 

Tech), Gonzalez Contract Services, 

Integrated Partners Group LLC, Kelly 

Services, Manpower, Inc., Rapid Global 

Business Solutions, Inc., TAC 

Worldwide, Trialon Corp., Trison 

Business Solutions, Wright K. 

Technologies, Interim Health Care and 

Advantage Technical Resourcing, 

Saginaw, MI; Amended Certification 

Regarding Eligibility To Apply for 

Worker Adjustment Assistance 

In accordance with section 223 of the 

Trade Act of 1974, as amended (‘‘Act’’), 

19 U.S.C. 2273, the Department of Labor 

issued a Certification of Eligibility to 

Apply for Worker Adjustment 

Assistance on July 14, 2009, applicable 

to workers of Delphi Steering, including 

on-site leased workers from Bartech and 

Securitas, Saginaw, Michigan. The 

notice was published in the Federal 

Register on September 2, 2009 (74 FR 

45477). The notice was amended on 

October 7, 2009, November 2, 2009 and 

July 22, 2010 to include on-site leased 

workers. The notices were published in 

the Federal Register on October 20, 

2009 (74 FR 53760–53761), December 8, 

2009 (74 FR 64716) and August 2, 2010 

(75 FR 45159–45160). 

At the request of the State Agency, the 

Department reviewed the certification 

for workers of the subject firm. The 

workers are engaged in the production 

of steering systems and components 

such as steering columns, gears, pumps 

and electronic power steering systems. 

The company reports that on-site 

leased workers from Advantage 

Technical Resourcing were employed 

on-site at the Saginaw, Michigan 

location of Delphi Steering. The 

Department has determined that these 

workers were sufficiently under the 

control of the subject firm to be 

considered leased workers. 

Based on these findings, the 

Department is amending this 

certification to include workers leased 

from Advantage Technical Resourcing 

working on-site at the Saginaw, 

Michigan location of Delphi Steering. 

The amended notice applicable to 

TA–W–70,460 is hereby issued as 

follows: 

All workers of Delphi Steering, including 

on-site leased workers from Bartech, 

Securitas, Acro Service Corp., Aerotek, Inc., 

Continental, Inc., Dynamic Corp., G-Tech 

Professional Staffing, Inc., GlobalEdge 

Technologies, Inc., (formerly CAE Tech), 

Gonzalez Contract Services, Integrated 

Partners Group LLC, Kelly Services, 

Manpower, Inc., Rapid Global Business 

Solutions, Inc., TAC Worldwide, Trialon 

Corp., Trison Business Solutions, Wright K. 

Technologies, Interim Health Care and 

Advantage Technical Resourcing, Saginaw, 

Michigan, who became totally or partially 

separated from employment on or after May 

20, 2008, through July 14, 2011, and all 

workers in the group threatened with total or 

partial separation from employment on date 

of certification through two years from the 

date of certification, are eligible to apply for 

adjustment assistance under Chapter 2 of 

Title II of the Trade Act of 1974, as amended. 

Signed at Washington, DC, this 17th day of 

February 2011. 

Michael W. Jaffe, 

Certifying Officer, Office of Trade Adjustment 

Assistance. 

[FR Doc. 2011–6191 Filed 3–16–11; 8:45 am] 

BILLING CODE 4510–FN–P 

DEPARTMENT OF LABOR 

Employment and Training 

Administration 

Notice of Determinations Regarding 

Eligibility To Apply for Worker 

Adjustment Assistance 

In accordance with Section 223 of the 

Trade Act of 1974, as amended (19 

U.S.C. 2273) the Department of Labor 

herein presents summaries of 

determinations regarding eligibility to 

apply for trade adjustment assistance for 

workers by (TA–W) number issued 

during the period of February 28, 2011 

through March 4, 2011. 

In order for an affirmative 

determination to be made for workers of 

a primary firm and a certification issued 

regarding eligibility to apply for worker 

adjustment assistance, each of the group 

eligibility requirements of Section 

222(a) of the Act must be met. 

I. Under Section 222(a)(2)(A), the 

following must be satisfied: 

(1) A significant number or proportion 

of the workers in such workers’ firm 

have become totally or partially 

separated, or are threatened to become 

totally or partially separated; 

(2) the sales or production, or both, of 

such firm have decreased absolutely; 

and 

(3) One of the following must be 

satisfied: 

(A) Imports of articles or services like 

or directly competitive with articles 

produced or services supplied by such 

firm have increased; 

(B) imports of articles like or directly 

competitive with articles into which one 

or more component parts produced by 

such firm are directly incorporated, 

have increased; 

(C) imports of articles directly 

incorporating one or more component 

parts produced outside the United 

States that are like or directly 

competitive with imports of articles 

incorporating one or more component 

parts produced by such firm have 

increased; 

(D) imports of articles like or directly 

competitive with articles which are 

produced directly using services 

supplied by such firm, have increased; 

and 

(4) the increase in imports contributed 

importantly to such workers’ separation 

or threat of separation and to the decline 

in the sales or production of such firm; 

or 

II. Section 222(a)(2)(B) all of the 

following must be satisfied: 

(1) A significant number or proportion 

of the workers in such workers’ firm 

have become totally or partially 

separated, or are threatened to become 

totally or partially separated; 

(2) One of the following must be 

satisfied: 

(A) There has been a shift by the 

workers’ firm to a foreign country in the 

production of articles or supply of 

services like or directly competitive 

with those produced/supplied by the 

workers’ firm; 

(B) there has been an acquisition from 

a foreign country by the workers’ firm 

of articles/services that are like or 

directly competitive with those 


srobinson on DSKHWCL6B1PROD with NOTICES